If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Update on Continuation Proposals

14 Jan 2016 07:00

RNS Number : 8126L
BlueCrest AllBlue Fund Ltd
14 January 2016
 



 

BlueCrest AllBlue Fund Limited (the "Company")

14 January 2016

Update on Continuation Proposals

Further to the Company's announcement on 9 December 2015, the Board is pleased to announce that, having completed its review of manager proposals received by the Company and consulted with its major shareholders, it proposes to recommend the replacement of its existing management arrangements with a mandate given to J.P. Morgan Asset Management ("JPMAM") group(1). The proposed appointment is subject to, amongst other things, detailed due diligence which is being performed on behalf of the Company and finalisation of engagement terms. In addition, the proposed appointment will be subject to shareholder approval as part of the re-organisation proposals (the "Proposals") to be put forward in due course.

As part of the Proposals, it is intended that the Company will invest substantially all of its assets (net of the cash exit opportunity described below) in the Highbridge Multi-Strategy Fund ("HMSF"). HMSF is a global multi-strategy hedge fund, managed by Highbridge Capital Management ("HCM"), focused on relative value strategies with idiosyncratic sources of return that invests in 12 distinct strategies across Fundamental Equity, Quantitative Equity, Event Driven Equity, Capital Structure Arbitrage, Convertible & Volatility Arbitrage, Fundamental Credit and Macro. Since its inception (1 January 1993) HMSF has achieved 10.76% annualised net returns, 6.89% annualised volatility and low beta relative to equity and credit indices.(2)

The JPMAM group is the largest manager of closed-end investment companies in the UK with 23 investment companies under its management and £9.2bn of assets under management(3). HCM was founded in 1992 as one of the industry's first multi-strategy hedge fund managers. Today, it is a global alternative investment manager with $29 billion in AUM(4). HCM maintains a staff of over 380 employees, including ~150 investment professionals and has offices in London, New York and Hong Kong.(4) HCM established a strategic partnership with JPMAM in 2004. All investment, capital allocation and risk management decisions for HMSF are independent of JPMAM.

It is currently intended to put forward the Proposals by the end of January/early February. As previously announced, the Proposals will provide shareholders with an opportunity to receive a full cash exit at NAV less costs (the "Cash Exit"), representing the net realisation proceeds from the AllBlue Limited redemptions, as soon as practicable following receipt by the Company. Proceeds of AllBlue Limited assets not capable of immediate realisation will subsequently be invested into HMSF with the exception of those proceeds due to shareholders pursuant to the Cash Exit.

Following implementation of the Proposals, it is intended to introduce a quarterly redemption facility, for up to 20% of the prevailing net asset value of the Company at NAV less costs, which may be implemented at the Board's discretion in each quarterly period. It is intended that net redemption proceeds would be paid to shareholders as soon as practicable following receipt by the Company.

A further announcement in relation to the Proposals will be made in due course.

For further information contact:

JTC (Guernsey) Limited, Secretary

Tel: +44 (0) 1481 702 400

Jefferies International Limited

Gary Gould/ Alex Collins

Tel: + 44 (0) 20 7029 8000

Dexion Capital Plc

Robin Bowie/ Katie Standley

Tel: +44 (0) 20 7832 0900

 

 

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS

There can be no assurance that the Company's or HMSF's return objectives will be realized or that the Company or HMSF will not experience losses.

 

(1) The brand name for the Asset Management business of J.P. Morgan Chase & Co.

(2) As of 30 November 2015 net of all applicable fees and expenses. Returns are estimated and unaudited for 2015.

(3) As of 31 December 2015.

(4) As of 1 December 2015.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUOUKRNWAAAAR
Date   Source Headline
6th Feb 20205:50 pmRNSNet Asset Value(s) - Weekly Estimate
6th Feb 20204:37 pmRNSNet Asset Value(s) Month End Final
31st Jan 20207:00 amRNSNotice of EGM
30th Jan 202010:57 amRNSNet Asset Value(s) - Weekly Estimate
23rd Jan 20204:51 pmRNSNet Asset Value(s) - Weekly Estimate
20th Jan 20204:53 pmRNSHolding(s) in Company
17th Jan 20209:28 amRNSNet Asset Value(s) - Weekly Estimate
10th Jan 20204:32 pmRNSCash Exit Payment
8th Jan 20204:53 pmRNSNet Asset Value(s) - Monthly Estimate
2nd Jan 20204:33 pmRNSNet Asset Value(s) - Weekly Estimate
31st Dec 201911:49 amRNS2019 Redemption Portfolio
30th Dec 20194:09 pmRNSNet Asset Value(s) - Weekly Estimate
30th Dec 201912:01 pmRNSNet Asset Value(s) - Month End Final
30th Dec 201910:30 amRNSHolding(s) in Company
23rd Dec 20191:06 pmRNSDirector/PDMR Shareholding
19th Dec 201911:51 amRNS2019 Redemption Portfolio
18th Dec 20195:23 pmRNSNet Asset Value(s) - Weekly Estimate
11th Dec 20195:13 pmRNSNet Asset Value(s)- Weekly Estimate
4th Dec 20194:59 pmRNSNet Asset Value(s) - Weekly Estimate
2nd Dec 20194:56 pmRNSNet Asset Value(s) - Weekly Estimate
29th Nov 20193:25 pmRNSNet Asset Value(s) - Month End Final
21st Nov 20193:11 pmRNSNet Asset Value(s) - Weekly Estimate
21st Nov 201910:54 amRNSHolding(s) in Company
18th Nov 201912:55 pmRNSDirector/PDMR Shareholding
13th Nov 20191:21 pmRNSNet Asset Value(s) - Weekly Estimate
12th Nov 20193:17 pmRNSChange of Adviser
12th Nov 20197:00 amRNSNet Asset Value(s) - Weekly Estimate
11th Nov 20197:00 amRNSNet Asset Value(s) - Monthly Estimate
30th Oct 20193:06 pmRNSNet Asset Value(s) - Weekly Estimate
30th Oct 20198:00 amRNSDirector Declaration
29th Oct 20199:47 amRNSHolding(s) in Company
28th Oct 201911:50 amRNSNet Asset Value(s) - Weekly Estimate
28th Oct 20199:34 amRNSUpdate from Manager
25th Oct 20193:11 pmRNSHolding(s) in Company
18th Oct 20194:21 pmRNSNet Asset Value(s) - Weekly Estimate
15th Oct 20199:14 amRNSCash Exit Payments
14th Oct 201910:19 amRNSDirectorate Change
9th Oct 20193:35 pmRNSHCC Proceeds and Weekly Estimated NAV
4th Oct 20193:53 pmRNSNet Asset Value(s) Month End Final
3rd Oct 20198:28 amRNSHolding(s) in Company
1st Oct 20198:00 amRNSTotal Voting Rights
27th Sep 20195:21 pmRNSNet Asset Value(s)- Weekly Estimate
26th Sep 201910:15 amRNSCorrection to Total Voting Rights
26th Sep 20199:24 amRNSHolding(s) in Company
25th Sep 201910:04 amRNSHolding(s) in Company
24th Sep 201911:58 amRNSHolding(s) in Company (replacement)
23rd Sep 20193:41 pmRNSHolding(s) in Company
19th Sep 20195:08 pmRNSHolding(s) in Company
19th Sep 20194:39 pmRNSHolding(s) in Company
18th Sep 20193:14 pmRNSChange of Name, TIDM, and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.